Skip to main content

Table 3 Pathological characteristics

From: Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study

Characteristic

Patients (n = 17)

Histology (PDAC), n (%)

17 (100.0)

T stage, n (%)

 T0

0 (0.0)

 Tis

0 (0.0)

 T1

4 (23.5)

 T2

1 (5.9)

 T3

12 (70.6)

N stage, n (%)

 N0

12 (70.6)

 N1

5 (29.4)

TNM stage, n (%)

 0

0 (0.0)

 IA

3 (17.6)

 IB

1 (5.9)

 IIA

8 (47.1)

 IIB

5 (29.4)

Negative microscopic resection margins, n (%)

 R0

16 (94.1)

 R1

1 (5.9)

Differentiation, n (%)

 Well-moderate

6 (35.3)

 Moderate-poor

10 (58.8)

 Other

1 (5.9)

Portal vein invasion status, n (%)

2 (11.8)

Microscopic lymphovascular invasion, n (%)

8 (47.1)

Microscopic perineural invasion, n (%)

5 (29.4)

Evans’ classification, n (%)

 I

0 (0.0)

 IIA

10 (58.8)

 IIB

5 (29.4)

 III

0 (0.0)

 IV

2 (11.8)

  1. Abbreviations: PDAC pancreatic ductal adenocarcinoma, TNM tumor-node-metastasis